By Michael Susin

AstraZeneca has agreed to settle product liability litigations related to Nexium and Prilosec in the U.S. by making a payment of $425 million, it said.

The Anglo-Swedish pharma giant said Tuesday that it has resolved the litigations under confidential terms.

The settled claims were pending in the Multidistrict Litigation District Court of New Jersey, as well as in the Delaware Superior Court and the New Jersey Superior Court.

The company said a single case remains pending in the U.S. District Court for the Middle District of Louisiana. Trial is scheduled for April 15, 2024.

Nexium and Prilosec are used to treat acid-related symptoms.

Write to Michael Susin at

(END) Dow Jones Newswires

10-03-23 0232ET